Table of Content

Table of Contents

Global Pediatric Drugs and Vaccines Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Pediatric Drugs and Vaccines Market by Value
2.2.1 Global Pediatric Drugs and Vaccines Revenue by Type
2.2.2 Global Pediatric Drugs and Vaccines Market by Value (%)
2.3 Global Pediatric Drugs and Vaccines Market by Production
2.3.1 Global Pediatric Drugs and Vaccines Production by Type
2.3.2 Global Pediatric Drugs and Vaccines Market by Production (%)

3. The Major Driver of Pediatric Drugs and Vaccines Industry
3.1 Historical & Forecast Global Pediatric Drugs and Vaccines Demand
3.2 Largest Application for Pediatric Drugs and Vaccines (2018-2028)
3.3 The Major Downstream Company in China Market 2022

4. Global and Regional Pediatric Drugs and Vaccines Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Pediatric Drugs and Vaccines Market
4.4 Mergers & Acquisitions, Expansion Plans

5. US Pediatric Drugs and Vaccines Production, Revenue (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Production Breakdown by Application
5.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

6. Europe Pediatric Drugs and Vaccines Production, Revenue (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Production Breakdown by Application
6.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

7. China Pediatric Drugs and Vaccines Production, Revenue (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Production Breakdown by Application
7.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

8. Japan Pediatric Drugs and Vaccines Production, Revenue (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Production Breakdown by Application
8.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

9. India Pediatric Drugs and Vaccines Production, Revenue (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Production Breakdown by Application
9.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

10. Korea Pediatric Drugs and Vaccines Production, Revenue (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Production Breakdown by Application
10.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

11. Southeast Asia Pediatric Drugs and Vaccines Production, Revenue (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Production Breakdown by Application
11.3 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.4 Current and Estimated Revenue Breakdown by Application (2018-2028)

12. Global Pediatric Drugs and Vaccines Average Price Trend
12.1 Market Price for Each Type of Pediatric Drugs and Vaccines in US (2018-2022)
12.2 Market Price for Each Type of Pediatric Drugs and Vaccines in Europe (2018-2022)
12.3 Market Price for Each Type of Pediatric Drugs and Vaccines in China (2018-2022)
12.4 Market Price for Each Type of Pediatric Drugs and Vaccines in Japan (2018-2022)
12.5 Market Price for Each Type of Pediatric Drugs and Vaccines in India (2018-2022)
12.6 Market Price for Each Type of Pediatric Drugs and Vaccines in Korea (2018-2022)
12.7 Market Price for Each Type of Pediatric Drugs and Vaccines in Southeast Asia (2018-2022)

13. Industrial Chain (Impact of COVID-19)
13.1 Pediatric Drugs and Vaccines Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Pediatric Drugs and Vaccines

14. Pediatric Drugs and Vaccines Competitive Landscape
14.1 Merck & Co., Inc. (USA)
14.1.1 Merck & Co., Inc. (USA) Company Profiles
14.1.2 Merck & Co., Inc. (USA) Product Introduction
14.1.3 Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 Abbott Laboratories (USA)
14.2.1 Abbott Laboratories (USA) Company Profiles
14.2.2 Abbott Laboratories (USA) Product Introduction
14.2.3 Abbott Laboratories (USA) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Amgen, Inc. (USA)
14.3.1 Amgen, Inc. (USA) Company Profiles
14.3.2 Amgen, Inc. (USA) Product Introduction
14.3.3 Amgen, Inc. (USA) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Eli Lilly and Company (USA)
14.4.1 Eli Lilly and Company (USA) Company Profiles
14.4.2 Eli Lilly and Company (USA) Product Introduction
14.4.3 Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 F. Hoffmann-La Roche Ltd (Switzerland)
14.5.1 F. Hoffmann-La Roche Ltd (Switzerland) Company Profiles
14.5.2 F. Hoffmann-La Roche Ltd (Switzerland) Product Introduction
14.5.3 F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Genentech, Inc. (USA)
14.6.1 Genentech, Inc. (USA) Company Profiles
14.6.2 Genentech, Inc. (USA) Product Introduction
14.6.3 Genentech, Inc. (USA) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 GlaxoSmithKline plc. (UK)
14.7.1 GlaxoSmithKline plc. (UK) Company Profiles
14.7.2 GlaxoSmithKline plc. (UK) Product Introduction
14.7.3 GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Janssen Biologics B.V. (USA)
14.8.1 Janssen Biologics B.V. (USA) Company Profiles
14.8.2 Janssen Biologics B.V. (USA) Product Introduction
14.8.3 Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Actelion Pharmaceuticals
14.9.1 Actelion Pharmaceuticals Company Profiles
14.9.2 Actelion Pharmaceuticals Product Introduction
14.9.3 Actelion Pharmaceuticals Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 AstraZeneca Plc. (UK)
14.10.1 AstraZeneca Plc. (UK) Company Profiles
14.10.2 AstraZeneca Plc. (UK) Product Introduction
14.10.3 AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Production, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Boehringer Ingelheim GmbH (Germany)
14.12 Bristol-Myers Squibb Company (USA)
14.13 Allergan, Inc. (USA)
14.14 Novartis AG (Switzerland)
14.15 Novo Nordisk A/S (Denmark)
14.16 Pfizer, Inc. (USA)
14.17 Sanofi S.A (France)
14.18 Shionogi Inc. (USA)
14.19 Shire Pharmaceuticals Group Plc. (UK)
15. Conclusion
16. Methodology and Data Source

List of Figure

List of Tables and Figures

Figure 1. Total Demand by Application of Pediatric Drugs and Vaccines Industry (Volume)
Figure 2. Pediatric Drugs and Vaccines Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Pediatric Drugs and Vaccines Revenue in 2022
Figure 5. US Pediatric Drugs and Vaccines Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Pediatric Drugs and Vaccines Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Pediatric Drugs and Vaccines Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Pediatric Drugs and Vaccines Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Pediatric Drugs and Vaccines Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Pediatric Drugs and Vaccines Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Pediatric Drugs and Vaccines Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Pediatric Drugs and Vaccines Revenue, by Type (Million USD) (2018-2028)
Table 4. Pediatric Drugs and Vaccines Production, by Type (K Unit) (2018-2028)
Table 5. Pediatric Drugs and Vaccines Demand (K Unit) by Application (2018-2028)
Table 6. Pediatric Drugs and Vaccines Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Pediatric Drugs and Vaccines Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Pediatric Drugs and Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Pediatric Drugs and Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Pediatric Drugs and Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Pediatric Drugs and Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Pediatric Drugs and Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Pediatric Drugs and Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Pediatric Drugs and Vaccines Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Pediatric Drugs and Vaccines in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Pediatric Drugs and Vaccines in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Pediatric Drugs and Vaccines in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Pediatric Drugs and Vaccines in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Pediatric Drugs and Vaccines in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Pediatric Drugs and Vaccines in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Pediatric Drugs and Vaccines in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Merck & Co., Inc. (USA) Profiles
Table 61. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Product Introduction
Table 62. Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 63. Merck & Co., Inc. (USA) Strategic initiatives
Table 64. Abbott Laboratories (USA) Profiles
Table 65. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Product Introduction
Table 66. Abbott Laboratories (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 67. Abbott Laboratories (USA) Strategic initiatives
Table 68. Amgen, Inc. (USA) Profiles
Table 69. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Product Introduction
Table 70. Amgen, Inc. (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 71. Amgen, Inc. (USA) Strategic initiatives
Table 72. Eli Lilly and Company (USA) Profiles
Table 73. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Product Introduction
Table 74. Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 75. Eli Lilly and Company (USA) Strategic initiatives
Table 76. F. Hoffmann-La Roche Ltd (Switzerland) Profiles
Table 77. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Product Introduction
Table 78. F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 79. F. Hoffmann-La Roche Ltd (Switzerland) Strategic initiatives
Table 80. Genentech, Inc. (USA) Profiles
Table 81. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Product Introduction
Table 82. Genentech, Inc. (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 83. Genentech, Inc. (USA) Strategic initiatives
Table 84. GlaxoSmithKline plc. (UK) Profiles
Table 85. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Product Introduction
Table 86. GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 87. GlaxoSmithKline plc. (UK) Strategic initiatives
Table 88. Janssen Biologics B.V. (USA) Profiles
Table 89. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Product Introduction
Table 90. Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 91. Janssen Biologics B.V. (USA) Strategic initiatives
Table 92. Actelion Pharmaceuticals Profiles
Table 93. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Product Introduction
Table 94. Actelion Pharmaceuticals Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 95. Actelion Pharmaceuticals Strategic initiatives
Table 97. AstraZeneca Plc. (UK) Profiles
Table 98. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Product Introduction
Table 99. AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 100. AstraZeneca Plc. (UK) Strategic initiatives
Table 101. Boehringer Ingelheim GmbH (Germany) Profiles
Table 102. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Product Introduction
Table 103. Boehringer Ingelheim GmbH (Germany) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 104. Boehringer Ingelheim GmbH (Germany) Strategic initiatives
Table 105. Bristol-Myers Squibb Company (USA) Profiles
Table 106. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Product Introduction
Table 107. Bristol-Myers Squibb Company (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 108. Bristol-Myers Squibb Company (USA) Strategic initiatives
Table 109. Allergan, Inc. (USA) Profiles
Table 110. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Product Introduction
Table 111. Allergan, Inc. (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 112. Allergan, Inc. (USA) Strategic initiatives
Table 113. Novartis AG (Switzerland) Profiles
Table 114. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Product Introduction
Table 115. Novartis AG (Switzerland) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 116. Novartis AG (Switzerland) Strategic initiatives
Table 117. Novo Nordisk A/S (Denmark) Profiles
Table 118. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Product Introduction
Table 119. Novo Nordisk A/S (Denmark) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 120. Novo Nordisk A/S (Denmark) Strategic initiatives
Table 121. Pfizer, Inc. (USA) Profiles
Table 122. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Product Introduction
Table 123. Pfizer, Inc. (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 124. Pfizer, Inc. (USA) Strategic initiatives
Table 125. Sanofi S.A (France) Profiles
Table 126. Sanofi S.A (France) Pediatric Drugs and Vaccines Product Introduction
Table 127. Sanofi S.A (France) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 128. Sanofi S.A (France) Strategic initiatives
Table 129. Shionogi Inc. (USA) Profiles
Table 130. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Product Introduction
Table 131. Shionogi Inc. (USA) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 132. Shionogi Inc. (USA) Strategic initiatives
Table 133. Shire Pharmaceuticals Group Plc. (UK) Profiles
Table 134. Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Product Introduction
Table 135. Shire Pharmaceuticals Group Plc. (UK) Pediatric Drugs and Vaccines Production (Unit), Revenue (Million USD) (2018-2022)
Table 136. Shire Pharmaceuticals Group Plc. (UK) Strategic initiatives